Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Clinical Significance of Genetic and Molecular Changes in Primary Myeloid Sarcoma]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 38387895 | PubTator, text mining | PubMed |
| Validating core therapeutic targets for osteoporosis treatment based on integrating network pharmacology and informatics. | SLAS Technol | 2024 | 38364892 | PubTator, text mining | PubMed |
| Under AI's lens: spotting mutations visually. | Blood Adv | 2024 | 38349670 | PubTator, text mining | PubMed |
| Cbfβ regulates Wnt/β-catenin, Hippo/Yap, and TGFβ signaling pathways in articular cartilage homeostasis and protects from ACLT surgery-induced osteoarthritis. | bioRxiv | 2024 | 38293189 | PubTator, text mining | PubMed |
| RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma. | Cell Death Dis | 2024 | 38286983 | PubTator, text mining | PubMed |
| Monitoring Genomic Structural Rearrangements Resulting from Gene Editing. | J Pers Med | 2024 | 38276232 | PubTator, text mining | PubMed |
| Development of a risk assessment model for cardiac injury in patients newly diagnosed with acute myeloid leukemia based on a multicenter, real-world analysis in China. | BMC Cancer | 2024 | 38273254 | PubTator, text mining | PubMed |
| The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease. | Cell Res | 2024 | 38267638 | PubTator, text mining | PubMed |
| The role and applications of extracellular vesicles in osteoporosis. | Bone Res | 2024 | 38263267 | PubTator, text mining | PubMed |
| The whole is greater than the sum of its parts: Long-read sequencing for solving clinical problems in haematology. | J Cell Mol Med | 2024 | 38260950 | PubTator, text mining | PubMed |
| The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine. | Clin Epigenetics | 2024 | 38254153 | PubTator, text mining | PubMed |
| Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion. | Cells | 2024 | 38247829 | PubTator, text mining | PubMed |
| MyeloDB: a multi-omics resource for multiple myeloma. | Funct Integr Genomics | 2024 | 38244111 | PubTator, text mining | PubMed |
| A computational exploration of global and temporal dynamics of selection pressure on HIV-1 Vif polymorphism. | Virus Res | 2024 | 38237808 | PubTator, text mining | PubMed |
| Gene Network Analyses Identify Co-regulated Transcription Factors and BACH1 as a Key Driver in Rheumatoid Arthritis Fibroblast-like Synoviocytes. | bioRxiv | 2024 | 38234777 | PubTator, text mining | PubMed |
| Lnc-PSMA8-1 activated by GEFT promotes rhabdomyosarcoma progression via upregulation of mTOR expression by sponging miR-144-3p. | BMC Cancer | 2024 | 38225540 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis Secondary to Refractory Acute Myeloid Leukemia Resolved after Second-Line Treatment with Azacitidine plus Venetoclax. | Mediterr J Hematol Infect Dis | 2024 | 38223479 | PubTator, text mining | PubMed |
| Epigenetic addition of m5C to HBV transcripts promotes viral replication and evasion of innate antiviral responses. | Cell Death Dis | 2024 | 38216565 | PubTator, text mining | PubMed |
| Prognostic significance of multiparametric flow cytometry minimal residual disease at two time points after induction in pediatric acute myeloid leukemia. | BMC Cancer | 2024 | 38195455 | PubTator, text mining | PubMed |
| Roles and signaling pathways of CITED1 in tumors: overview and novel insights. | J Int Med Res | 2024 | 38190845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers?page=6